{"id":"https://openalex.org/W2016109861","doi":"https://doi.org/10.1111/j.1476-5381.1990.tb13010.x","title":"\u03b12\u2010Adrenoceptor subtypes and imidazoline\u2010like binding sites in the rat brain","display_name":"\u03b12\u2010Adrenoceptor subtypes and imidazoline\u2010like binding sites in the rat brain","alternate_titles":[],"publication_year":1990,"publication_date":"1990-04-01","ids":{"openalex":"https://openalex.org/W2016109861","doi":"https://doi.org/10.1111/j.1476-5381.1990.tb13010.x","mag":"2016109861","pmid":"https://pubmed.ncbi.nlm.nih.gov/1972896","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/1917565"},"language":"en","primary_location":{"id":"doi:10.1111/j.1476-5381.1990.tb13010.x","doi":"https://doi.org/10.1111/j.1476-5381.1990.tb13010.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1476-5381.1990.tb13010.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1476-5381.1990.tb13010.x","source":{"id":"https://openalex.org/S55107261","display_name":"British Journal of Pharmacology","issn_l":"0007-1188","issn":["0007-1188","1476-5381"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Pharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2016109861"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1476-5381.1990.tb13010.x","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5006330314","display_name":"Christine M. Brown","orcid":"https://orcid.org/0000-0001-5459-9571","observed_orcids":["https://orcid.org/0000-0001-5459-9571"]},"institutions":[{"id":"https://openalex.org/I4210120742","display_name":"Walgreens Boots Alliance (United Kingdom)","ror":"https://ror.org/02ktw5c97","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210120742"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"C.M. Brown","raw_affiliation_strings":["Department of Pharmacology, Syntex Research Centre, Edinburgh","Boots Pharmaceuticals Research Dept., Nottingham NG2 3AA","Department of Pharmacology, Syntex Research Centre, Edinburgh, EH14 4AP"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Syntex Research Centre, Edinburgh","institution_ids":[]},{"raw_affiliation_string":"Boots Pharmaceuticals Research Dept., Nottingham NG2 3AA","institution_ids":["https://openalex.org/I4210120742"]},{"raw_affiliation_string":"Department of Pharmacology, Syntex Research Centre, Edinburgh, EH14 4AP","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011577349","display_name":"Alison C. MacKinnon","orcid":"https://orcid.org/0000-0002-7967-4141","observed_orcids":["https://orcid.org/0000-0002-7967-4141"]},"institutions":[{"id":"https://openalex.org/I4210120742","display_name":"Walgreens Boots Alliance (United Kingdom)","ror":"https://ror.org/02ktw5c97","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210120742"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"A.C. MacKinnon","raw_affiliation_strings":["Boots Pharmaceuticals Research Dept., Nottingham NG2 3AA","Department of Pharmacology, Syntex Research Centre, Edinburgh, EH14 4AP"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boots Pharmaceuticals Research Dept., Nottingham NG2 3AA","institution_ids":["https://openalex.org/I4210120742"]},{"raw_affiliation_string":"Department of Pharmacology, Syntex Research Centre, Edinburgh, EH14 4AP","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059319160","display_name":"John Christie McGrath","orcid":"https://orcid.org/0000-0002-5276-0381","observed_orcids":["https://orcid.org/0000-0002-5276-0381"]},"institutions":[{"id":"https://openalex.org/I7882870","display_name":"University of Glasgow","ror":"https://ror.org/00vtgdb53","country_code":"GB","type":"education","lineage":["https://openalex.org/I7882870"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"J.C. McGrath","raw_affiliation_strings":["Autonomic Physiology Unit, Institute of Physiology, University of Glasgow, G12 8QQ","Department of Pharmacology, Syntex Research Centre, Edinburgh, EH14 4AP"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Autonomic Physiology Unit, Institute of Physiology, University of Glasgow, G12 8QQ","institution_ids":["https://openalex.org/I7882870"]},{"raw_affiliation_string":"Department of Pharmacology, Syntex Research Centre, Edinburgh, EH14 4AP","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080135978","display_name":"Michael Spedding","orcid":"https://orcid.org/0000-0002-1248-8221","observed_orcids":["https://orcid.org/0000-0002-1248-8221"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. Spedding","raw_affiliation_strings":["Department of Pharmacology, Syntex Research Centre, Edinburgh, EH14 4AP"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Syntex Research Centre, Edinburgh, EH14 4AP","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5002791765","display_name":"Andrew T. Kilpatrick","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210120742","display_name":"Walgreens Boots Alliance (United Kingdom)","ror":"https://ror.org/02ktw5c97","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210120742"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"A.T. Kilpatrick","raw_affiliation_strings":["Boots Pharmaceuticals Research Dept., Nottingham NG2 3AA","Department of Pharmacology, Syntex Research Centre, Edinburgh, EH14 4AP"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boots Pharmaceuticals Research Dept., Nottingham NG2 3AA","institution_ids":["https://openalex.org/I4210120742"]},{"raw_affiliation_string":"Department of Pharmacology, Syntex Research Centre, Edinburgh, EH14 4AP","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5002791765"],"corresponding_institution_ids":["https://openalex.org/I4210120742"],"apc_list":{"value":4780,"currency":"USD","value_usd":4780},"apc_paid":null,"fwci":4.3057,"has_fulltext":true,"cited_by_count":123,"citation_normalized_percentile":{"value":0.95411646,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"99","issue":"4","first_page":"803","last_page":"809"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":0.8690999746322632,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":0.8690999746322632,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.09830000251531601,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.026599999517202377,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/alpha2-adrenoceptor-subtypes","display_name":"alpha2-adrenoceptor subtypes","score":0.8679999709129333},{"id":"https://openalex.org/keywords/imidazoline-binding-sites","display_name":"imidazoline binding sites","score":0.8479999899864197},{"id":"https://openalex.org/keywords/rat-cerebral-cortex","display_name":"rat cortex","score":0.5410000085830688},{"id":"https://openalex.org/keywords/hippocampus","display_name":"hippocampus","score":0.8529999852180481},{"id":"https://openalex.org/keywords/alpha2a-adrenoceptor","display_name":"alpha2A-adrenoceptor","score":0.7310000061988831},{"id":"https://openalex.org/keywords/alpha2b-adrenoceptor","display_name":"alpha2B-adrenoceptor","score":0.9990000128746033},{"id":"https://openalex.org/keywords/prazosin","display_name":"prazosin","score":0.781000018119812},{"id":"https://openalex.org/keywords/cirazoline","display_name":"cirazoline","score":0.8349999785423279},{"id":"https://openalex.org/keywords/binding-site-heterogeneity","display_name":"binding site heterogeneity","score":0.48100000619888306}],"concepts":[{"id":"https://openalex.org/C2780939551","wikidata":"https://www.wikidata.org/wiki/Q5987770","display_name":"Idazoxan","level":5,"score":0.9277545213699341},{"id":"https://openalex.org/C2777676773","wikidata":"https://www.wikidata.org/wiki/Q412226","display_name":"Yohimbine","level":4,"score":0.8227100372314453},{"id":"https://openalex.org/C123605464","wikidata":"https://www.wikidata.org/wiki/Q1659850","display_name":"Imidazoline receptor","level":2,"score":0.6912779808044434},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5455101132392883},{"id":"https://openalex.org/C107824862","wikidata":"https://www.wikidata.org/wiki/Q616005","display_name":"Binding site","level":2,"score":0.5411826968193054},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.47701430320739746},{"id":"https://openalex.org/C2781005078","wikidata":"https://www.wikidata.org/wiki/Q424442","display_name":"Methysergide","level":4,"score":0.4521512985229492},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4429953396320343},{"id":"https://openalex.org/C2780648677","wikidata":"https://www.wikidata.org/wiki/Q425296","display_name":"Prazosin","level":4,"score":0.36684444546699524},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.29879581928253174},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2500947117805481},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.23141434788703918},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.10771423578262329},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.07391232252120972}],"mesh":[{"descriptor_ui":"D000316","descriptor_name":"Adrenergic alpha-Agonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001923","descriptor_name":"Brain Chemistry","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D002417","descriptor_name":"Cattle","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002540","descriptor_name":"Cerebral Cortex","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D002540","descriptor_name":"Cerebral Cortex","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D004146","descriptor_name":"Dioxanes","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006624","descriptor_name":"Hippocampus","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D006624","descriptor_name":"Hippocampus","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007093","descriptor_name":"Imidazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D007211","descriptor_name":"Indoles","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D007700","descriptor_name":"Kinetics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008784","descriptor_name":"Methysergide","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D011919","descriptor_name":"Rats, Inbred Strains","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011942","descriptor_name":"Receptors, Adrenergic, alpha","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D011942","descriptor_name":"Receptors, Adrenergic, alpha","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D011955","descriptor_name":"Receptors, Drug","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D011955","descriptor_name":"Receptors, Drug","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D013764","descriptor_name":"Tetrahydronaphthalenes","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D015016","descriptor_name":"Yohimbine","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D017371","descriptor_name":"8-Hydroxy-2-(di-n-propylamino)tetralin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019329","descriptor_name":"Idazoxan","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D054755","descriptor_name":"Imidazoline Receptors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D066298","descriptor_name":"In Vitro Techniques","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1111/j.1476-5381.1990.tb13010.x","doi":"https://doi.org/10.1111/j.1476-5381.1990.tb13010.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1476-5381.1990.tb13010.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1476-5381.1990.tb13010.x","source":{"id":"https://openalex.org/S55107261","display_name":"British Journal of Pharmacology","issn_l":"0007-1188","issn":["0007-1188","1476-5381"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Pharmacology","raw_type":"journal-article"},{"id":"pmid:1972896","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/1972896","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of pharmacology","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:1917565","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC1917565/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Br J Pharmacol","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1111/j.1476-5381.1990.tb13010.x","doi":"https://doi.org/10.1111/j.1476-5381.1990.tb13010.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1476-5381.1990.tb13010.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1476-5381.1990.tb13010.x","source":{"id":"https://openalex.org/S55107261","display_name":"British Journal of Pharmacology","issn_l":"0007-1188","issn":["0007-1188","1476-5381"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.428600013256073,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2016109861.pdf","grobid_xml":"https://content.openalex.org/works/W2016109861.grobid-xml"},"referenced_works_count":33,"referenced_works":["https://openalex.org/W1775749144","https://openalex.org/W1812768215","https://openalex.org/W1910393924","https://openalex.org/W1965250107","https://openalex.org/W1972229598","https://openalex.org/W1974106083","https://openalex.org/W1974411012","https://openalex.org/W1990258587","https://openalex.org/W1992056227","https://openalex.org/W1999691892","https://openalex.org/W2006809246","https://openalex.org/W2012335673","https://openalex.org/W2014321807","https://openalex.org/W2014740637","https://openalex.org/W2017736705","https://openalex.org/W2018255163","https://openalex.org/W2026499926","https://openalex.org/W2035144502","https://openalex.org/W2042706478","https://openalex.org/W2043813981","https://openalex.org/W2044938337","https://openalex.org/W2056544132","https://openalex.org/W2065845925","https://openalex.org/W2074631079","https://openalex.org/W2079263321","https://openalex.org/W2086149148","https://openalex.org/W2093744068","https://openalex.org/W2157644893","https://openalex.org/W2244959895","https://openalex.org/W2273330334","https://openalex.org/W2408148837","https://openalex.org/W2468488662","https://openalex.org/W4243188907"],"related_works":["https://openalex.org/W2018163032","https://openalex.org/W2060927932","https://openalex.org/W2074886229","https://openalex.org/W2018255163","https://openalex.org/W2024709967","https://openalex.org/W1975258718","https://openalex.org/W2044938337","https://openalex.org/W2017736705","https://openalex.org/W2055805920","https://openalex.org/W2017600547"],"abstract_inverted_index":{"1.":[0],"The":[1,192,283,334],"binding":[2,27,108,136,145,170,203,213,321,345,376],"of":[3,16,26,184,194,246,285,337,369,375],"[3H]-yohimbine":[4,31,169,290],"and":[5,10,15,47,80,137,159,166,176,198,207,220,260,270,279,297,339,358,363],"[3H]-idazoxan":[6,61,107,185,202,301,317],"to":[7,100,133,143,146,204],"rat":[8,125,325,348,362],"cortex":[9,34,67,126,206,326,349],"hippocampus":[11,48,81,208],"is":[12,98,122,131,141,328,350],"rapid,":[13],"reversible":[14],"high":[17,175,233,255],"affinity.":[18],"Saturation":[19],"data":[20],"indicate":[21,152,288],"that":[22,153,253,289,327,342],"a":[23,174,227,251,307],"single":[24],"population":[25],"sites":[28],"exist":[29],"for":[30,218,231,236],"in":[32,65,124,243,323,347,360],"the":[33,66,154,160,182,205,212,232,244,271,294,311,324,343,353],"(Bmax":[35,49,68,82,110],"121":[36],"+/-":[37,44,51,58,70,77,84,91,112,119],"10":[38],"fmol":[39,53,72,86,114],"mg-1,":[40],"protein;":[41,55,74,88,116],"Kd":[42,56,75,89,117],"5.2":[43],"0.9":[45,78],"nM)":[46,79,121],"72":[50],"6":[52,85],"mg-1":[54,73,87,115],"5.8":[57],"0.7":[59],"nM).":[60],"labels":[62,250,291,302,318],"one":[63],"site":[64,109,214,235,252,322,346,354],"87":[69],"8":[71],"4.1":[76],"30":[83],"3.5":[90],"0.5":[92],"nM),":[93],"when":[94],"3":[95,138,247],"microM":[96,129,139,248],"phentolamine":[97],"used":[99,132],"define":[101,134],"non-specific":[102,135],"binding.":[103],"A":[104],"second":[105],"distinct":[106,330],"110":[111],"21":[113],"3.6":[118],"0.07":[120],"identified":[123],"if":[127],"0.3":[128],"cirazoline":[130],"yohimbine":[140],"included":[142],"prevent":[144],"alpha":[147,155,223,239,272,295,298,304,312,332],"2-adrenoceptors.":[148,333],"2.":[149],"Displacement":[150],"studies":[151],"1-adrenoceptor":[156],"antagonist":[157],"prazosin":[158,219,237],"5-HT1":[161],"ligands":[162],"8-OH-DPAT,":[163,195],"RU":[164,196],"24969":[165,197],"methysergide":[167,199],"differentiate":[168],"into":[171],"two":[172,292],"components;":[173],"low":[177,216,263,335],"affinity":[178,217,234,256,264,336],"site.":[179],"In":[180,225,315],"contrast":[181],"displacement":[183],"by":[186,356],"each":[187],"ligand":[188],"was":[189],"monophasic.":[190],"3.":[191],"affinities":[193],"determined":[200],"against":[201],"correlate":[209],"significantly":[210],"with":[211,306,310],"displaying":[215],"previously":[221],"designated":[222,238],"2A.":[224],"contrast,":[226],"poor":[228],"correlation":[229],"exists":[230],"2B.":[240],"4.":[241],"[3H]-idazoxan,":[242],"presence":[245],"yohimbine,":[249,275],"displays":[254],"towards":[257,265],"cirazoline,":[258],"naphazoline":[259],"guanabenz,":[261],"but":[262],"clonidine,":[266],"p-aminoclonidine,":[267],"adrenaline,":[268],"noradrenaline":[269],"2-adrenoceptor":[273,305],"antagonists":[274],"rauwolscine,":[276],"WY":[277],"26703":[278],"BDF":[280],"6143.":[281],"5.":[282],"results":[284],"this":[286,373],"study":[287],"sites;":[293],"2A-":[296],"2B-adrenoceptors":[299],"whereas":[300],"an":[303,319],"profile":[308],"consistent":[309],"2A-adrenoceptor":[313],"subtype.":[314],"addition,":[316],"imidazoline":[320],"pharmacologically":[329],"from":[331,352],"clonidine":[338],"p-aminoclonidine":[340],"indicates":[341],"imidazoline-like":[344],"different":[351],"labelled":[355],"[3H]-clonidine":[357],"[3H]-p-aminoclonidine":[359],"human,":[361],"bovine":[364],"brain":[365],"stem,":[366],"providing":[367],"evidence":[368],"potential":[370],"heterogeneity":[371],"within":[372],"class":[374],"sites.":[377]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2016109861","counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2017,"cited_by_count":3},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
